In addition, B7-H3 expression in tumor vasculature was also correlated with poor survival, suggesting that this ligand might play an important role in tumor cell migration [15, 16]; therefore, B7-H3 might be a useful target for tumor-specific antiangiogenic therapies [17]. This evidence concerns the gene CD276 and neoplasm.